Fitzbio Research HubEducational content only — not medical advice

Tissue research

ARA-290 (Cibinetide)

An erythropoietin-derived peptide studied in tissue-protection and neuropathy research.

28 connected records28 graded citations0 external identifiers

Research context

An erythropoietin-derived peptide studied in tissue-protection and neuropathy research.

Regulatory note: Verify local laws, product approval and professional guidance before any human use. This profile is not a recommendation for use.

Evidence map

Claims linked to original records.

Evidence levels describe study design. They do not by themselves establish safety or effectiveness.

Not yet classified

Alburghaif AH, Al-Hussaniy HA, Maan J, Razzaq NA

Pharmacological Management of Diabetic Neuropathy: Current Evidence, Clinical Positioning, and Emerging Therapeutic Targets.

pubmed
Not yet classified

Sun Y, Song B, Zhang Y, Zhang Y, Zhou L

Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.

pubmed 2026
Not yet classified

Winicki NM, Nanavati AP, Morrell CH, Moen JM, Axsom JE, Krawczyk M, Petrashevskaya NN, Beyman MG, Ramirez C, Alfaras I, Mitchell SJ, Juhaszova M, Riordon DR, Wang M, Zhang J, Cerami A, Brines M, Sollott SJ, de Cabo R, Lakatta EG

A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan.

pubmed 2026
Not yet classified

Awida Z, Bachar A, Saed H, Gorodov A, Ben-Califa N, Ibrahim M, Kolomansky A, Iden JA, Graniewitz Visacovsky L, Liron T, Hiram-Bab S, Brines M, Gabet Y, Neumann D

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.

pubmed
Not yet classified

Yao M, Domogatskaya A, Ågren N, Watanabe M, Tokodai K, Brines M, Cerami A, Ericzon BG, Kumagai-Braesch M, Lundgren T

Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation.

pubmed
Systematic review

Rendell MS

The time to develop treatments for diabetic neuropathy.

pubmed 2021
Not yet classified

Lois N, Gardner E, McFarland M, Armstrong D, McNally C, Lavery NJ, Campbell C, Kirk RI, Bajorunas D, Dunne A, Cerami A, Brines M

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

pubmed
Clinical trial

The purpose of this study is to determine whether ARA 290, a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis. Brief interaction of ARA 290 with the innate repair receptor results in anti-apoptotic and anti-inflammatory activities in myriad...

Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis

clinicaltrials 2014
Clinical trial

The purpose of this study is to determine whether a non-hematopoietic erythropoietin analogue, ARA 290, exerts beneficial effects on blood glucose levels and insulin secretion in persons with prediabetes (impaired glucose tolerance, IGT, or impaired fasting glucose, IFG), or drug-naive type 2 diabetes. The study...

ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)

clinicaltrials 2013
Clinical trial

ARA 290-DMO is a prospective, open label, interventional, single centre, investigator led, phase II trial to examine the effect of ARA 290 on diabetic macular oedema in patients with type 1 or 2 diabetes. The aim or primary objective of the study was to determine...

The Use of ARA290 for the Treatment of Diabetic Macular Oedema

clinicaltrials 2018
Clinical trial

Studies on the hormone Erythropoietin (EPO) have indicated that EPO may have antidepressant properties. However, EPO may cause serious side-effects with repeated administration (thrombosis), which limits its usefulness as an antidepressant. ARA290 is a peptide that does not have the effects of EPO on blood...

Cognitive and Neural Effects of ARA290

clinicaltrials 2014
Not yet classified

· Ankara University

Güvenlik-özgürlük ikileminde teröre yönelik tutumlar

crossref 2004
Not yet classified

· University of Notre Dame Press

THE LOOK AND THE VOICE

crossref 2024
Not yet classified

Jacqueline Boyd-McConville, Noemi Lois · Springer Science and Business Media LLC

Use of ARA 290 for the treatment of diabetic macular oedema

crossref 2015
Not yet classified

PurposeThe purpose of this paper is to examine the effect of environmental disclosure on firm efficiency of the listed firms in Pakistan.Design/methodology/approachThe study uses secondary sources such as sustainability reports, annual reports and company websites to collect the data. A sample of 46 large firms...

Environmental disclosure and firm efficiency: a study of Pakistani firms

crossref 2021
Not yet classified

Ara kazanç ticareti, spekülatif bir finansal işlem ve kaldıraçlı döviz kuru pozisyonudur. Bu nedenle, ara kazanç ticareti pozisyonlarında meydana gelebilecek ani bir çözülme, yüksek faiz oranına sahip para biriminin sert bir şekilde değer kaybetmesine ve dolayısıyla döviz kuru oynaklığının artmasına yol açmakta; küresel dengesizliklere ve...

ARA KAZANÇ TİCARETİNDEKİ (CARRY TADE) ÇÖZÜLMENİN ASİMETRİK ETKİLERİ: TÜRKİYE ÜZERİNE BİR UYGULAMA

crossref 2021
Not yet classified

· Universidade de Sao Paulo, Agencia USP de Gestao da Informacao Academica (AGUIA)

Revista ARA

crossref
Not yet classified

Wenjia Zhang, Guanling Yu, Mengyuan Zhang · Elsevier BV

ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception

crossref 2016
Not yet classified

· Massachusetts Medical Society

Possible Bone-Marrow Depression by Ara-A Therapy for Disseminated Herpes Zoster

crossref 1974
Not yet classified

Manfred Nairz, David Haschka, Stefanie Dichtl, Thomas Sonnweber, Andrea Schroll, Malte Aßhoff et al. · Scientific Reports · 21 citations

Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis

openalex 2017
Not yet classified

Noemi Lois, Evie Gardner, Margaret McFarland, David G. Armstrong, Christine McNally, Nuala Jane Lavery et al. · Journal of Clinical Medicine · 11 citations

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema

openalex 2020
Not yet classified

Zamzam Awida, Almog Bachar, Hussam Saed, Anton Gorodov, Nathalie Ben‐Califa, Maria Ibrahim et al. · International Journal of Molecular Sciences · 7 citations

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice

openalex 2021
Not yet classified

Michael L. Brines, Daniel A. Culver, Maryam Ferdousi, Martijn Rudolf Tannemaat, Monique van Velzen, Albert Dahan et al. · Scientific Reports · 89 citations

Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy

openalex 2018
Not yet classified

Sukanya Suresh, Praveen Kumar Rajvanshi, Constance Tom Noguchi · Frontiers in Physiology · 211 citations

The Many Facets of Erythropoietin Physiologic and Metabolic Response

openalex 2020
Not yet classified

Bo Peng, Gangcheng Kong, Cheng Yu Yang, Yingzi Ming · Cell Death and Disease · 179 citations

Erythropoietin and its derivatives: from tissue protection to immune regulation

openalex 2020
Not yet classified

Robert Phillip Baughman, Dominique Valeyre, Peter J. Korsten, Alexander G. Mathioudakis, Wim A Wuyts, Athol Umfrey Wells et al. · European Respiratory Journal · 632 citations

ERS clinical practice guidelines on treatment of sarcoidosis

openalex 2021
Not yet classified

Shazli Azmi, Maria Jeziorska, Maryam Ferdousi, Ioannis Nikolaos Petropoulos, Georgios Ponirakis, Andrew G. Marshall et al. · Diabetologia · 122 citations

Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation

openalex 2019
Not yet classified

Luansritisakul C, Chiang MC, Burns SL, Fonseca ACG

Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.

pubmed

Connected data hub

Records with source provenance.

Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.

Publication

8 records
pubmedAutomated import

Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.

Sun Y, Song B, Zhang Y, Zhang Y, Zhou L

416599752026-09-27
pubmedAutomated import

A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan.

Winicki NM, Nanavati AP, Morrell CH, Moen JM, Axsom JE, Krawczyk M, Petrashevskaya NN, Beyman MG, Ramirez C, Alfaras I, Mitchell SJ, Juhaszova M, Riordon DR, Wang M, Zhang J, Cerami A, Brines M, Sollott SJ, de Cabo...

367418362026-09-27
pubmedAutomated import

The time to develop treatments for diabetic neuropathy.

Rendell MS

334235572021-02-01
pubmedAutomated import

Pharmacological Management of Diabetic Neuropathy: Current Evidence, Clinical Positioning, and Emerging Therapeutic Targets.

Alburghaif AH, Al-Hussaniy HA, Maan J, Razzaq NA

4269383627 Sep 2026
pubmedAutomated import

Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.

Luansritisakul C, Chiang MC, Burns SL, Fonseca ACG

4263586527 Sep 2026
pubmedAutomated import

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.

Awida Z, Bachar A, Saed H, Gorodov A, Ben-Califa N, Ibrahim M, Kolomansky A, Iden JA, Graniewitz Visacovsky L, Liron T, Hiram-Bab S, Brines M, Gabet Y, Neumann D

3500848227 Sep 2026
pubmedAutomated import

Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation.

Yao M, Domogatskaya A, Ågren N, Watanabe M, Tokodai K, Brines M, Cerami A, Ericzon BG, Kumagai-Braesch M, Lundgren T

3449850927 Sep 2026
pubmedAutomated import

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

Lois N, Gardner E, McFarland M, Armstrong D, McNally C, Lavery NJ, Campbell C, Kirk RI, Bajorunas D, Dunne A, Cerami A, Brines M

3267428027 Sep 2026

Scholarly Work

8 records
crossrefAutomated import

THE LOOK AND THE VOICE

· University of Notre Dame Press

10.2307/jj.21995744.342024-08-01
crossrefAutomated import

Environmental disclosure and firm efficiency: a study of Pakistani firms

PurposeThe purpose of this paper is to examine the effect of environmental disclosure on firm efficiency of the listed firms in Pakistan.Design/methodology/approachThe study uses secondary sources such as sustainability reports, annual reports and company websites to collect the...

10.1108/ara-05-2019-01002021-03-23
crossrefAutomated import

ARA KAZANÇ TİCARETİNDEKİ (CARRY TADE) ÇÖZÜLMENİN ASİMETRİK ETKİLERİ: TÜRKİYE ÜZERİNE BİR UYGULAMA

Ara kazanç ticareti, spekülatif bir finansal işlem ve kaldıraçlı döviz kuru pozisyonudur. Bu nedenle, ara kazanç ticareti pozisyonlarında meydana gelebilecek ani bir çözülme, yüksek faiz oranına sahip para biriminin sert bir şekilde değer kaybetmesine ve dolayısıyla döviz kuru...

10.18092/ulikidince.6860452021-01-25
crossrefAutomated import

ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception

Wenjia Zhang, Guanling Yu, Mengyuan Zhang · Elsevier BV

10.1016/j.peptides.2016.01.0032016-02-01
crossrefAutomated import

Use of ARA 290 for the treatment of diabetic macular oedema

Jacqueline Boyd-McConville, Noemi Lois · Springer Science and Business Media LLC

10.1186/isrctn169622552015-06-25
crossrefAutomated import

Güvenlik-özgürlük ikileminde teröre yönelik tutumlar

· Ankara University

10.1501/00018582004-01-01
crossrefAutomated import

Possible Bone-Marrow Depression by Ara-A Therapy for Disseminated Herpes Zoster

· Massachusetts Medical Society

10.1056/nejm1974041829016251974-04-18
crossrefAutomated import

Revista ARA

· Universidade de Sao Paulo, Agencia USP de Gestao da Informacao Academica (AGUIA)

10.11606/issn.2525-835427 Sep 2026

Article

8 records
openalexAutomated import

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice

Zamzam Awida, Almog Bachar, Hussam Saed, Anton Gorodov, Nathalie Ben‐Califa, Maria Ibrahim et al. · International Journal of Molecular Sciences · 7 citations

10.3390/ijms230100552021-12-21
openalexAutomated import

ERS clinical practice guidelines on treatment of sarcoidosis

Robert Phillip Baughman, Dominique Valeyre, Peter J. Korsten, Alexander G. Mathioudakis, Wim A Wuyts, Athol Umfrey Wells et al. · European Respiratory Journal · 632 citations

10.1183/13993003.04079-20202021-06-17
openalexAutomated import

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema

Noemi Lois, Evie Gardner, Margaret McFarland, David G. Armstrong, Christine McNally, Nuala Jane Lavery et al. · Journal of Clinical Medicine · 11 citations

10.3390/jcm90722252020-07-14
openalexAutomated import

Erythropoietin and its derivatives: from tissue protection to immune regulation

Bo Peng, Gangcheng Kong, Cheng Yu Yang, Yingzi Ming · Cell Death and Disease · 179 citations

10.1038/s41419-020-2276-82020-02-03
openalexAutomated import

The Many Facets of Erythropoietin Physiologic and Metabolic Response

Sukanya Suresh, Praveen Kumar Rajvanshi, Constance Tom Noguchi · Frontiers in Physiology · 211 citations

10.3389/fphys.2019.015342020-01-17
openalexAutomated import

Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation

Shazli Azmi, Maria Jeziorska, Maryam Ferdousi, Ioannis Nikolaos Petropoulos, Georgios Ponirakis, Andrew G. Marshall et al. · Diabetologia · 122 citations

10.1007/s00125-019-4897-y2019-06-07
openalexAutomated import

Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy

Michael L. Brines, Daniel A. Culver, Maryam Ferdousi, Martijn Rudolf Tannemaat, Monique van Velzen, Albert Dahan et al. · Scientific Reports · 89 citations

10.1038/s41598-018-23107-w2018-03-12
openalexAutomated import

Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis

Manfred Nairz, David Haschka, Stefanie Dichtl, Thomas Sonnweber, Andrea Schroll, Malte Aßhoff et al. · Scientific Reports · 21 citations

10.1038/s41598-017-13046-32017-10-06

Clinical Trial

4 records
clinicaltrialsAutomated import

The Use of ARA290 for the Treatment of Diabetic Macular Oedema

ARA 290-DMO is a prospective, open label, interventional, single centre, investigator led, phase II trial to examine the effect of ARA 290 on diabetic macular oedema in patients with type 1 or 2 diabetes. The aim or primary...

NCT066269712018-03-28
clinicaltrialsAutomated import

Cognitive and Neural Effects of ARA290

Studies on the hormone Erythropoietin (EPO) have indicated that EPO may have antidepressant properties. However, EPO may cause serious side-effects with repeated administration (thrombosis), which limits its usefulness as an antidepressant. ARA290 is a peptide that does not...

NCT020707832014-02-23
clinicaltrialsAutomated import

Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis

The purpose of this study is to determine whether ARA 290, a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis. Brief interaction of ARA 290 with the innate repair receptor results...

NCT020396872014-01-16
clinicaltrialsAutomated import

ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)

The purpose of this study is to determine whether a non-hematopoietic erythropoietin analogue, ARA 290, exerts beneficial effects on blood glucose levels and insulin secretion in persons with prediabetes (impaired glucose tolerance, IGT, or impaired fasting glucose, IFG),...

NCT019335292013-08-28
Responsible use of information

Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.